Related Articles by Review for PMID: 31869178

Year	Number of Results
1987	1
1989	1
1990	1
1991	3
1992	2
1994	2
1997	2
1998	1
2000	1
2002	1
2003	2
2005	1
2006	3
2008	3
2009	1
2010	3
2011	3
2012	5
2013	1
2014	2
2015	2
2016	2
2019	1
2020	3
2022	2
2023	2
2024	1
2025	1

1

Nakashima J, Patel P, Preuss CV. Nakashima J, et al. 2024 Feb 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Feb 15. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31869178 Free Books & Documents.

2

Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.

Segars LW, Gales BJ. Segars LW, et al. Clin Pharm. 1992 Jun;11(6):514-28. Clin Pharm. 1992. PMID: 1600685 Review.

3

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Wang Y, Parker CE, Bhanji T, Feagan BG, MacDonald JK. Wang Y, et al. Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD000543. doi: 10.1002/14651858.CD000543.pub4. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Aug 12;8:CD000543. doi: 10.1002/14651858.CD000543.pub5. PMID: 27101467 Free PMC article. Updated. Review.

4

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.

Feagan BG, Macdonald JK. Feagan BG, et al. Cochrane Database Syst Rev. 2012 Oct 17;10:CD000543. doi: 10.1002/14651858.CD000543.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 Apr 21;4:CD000543. doi: 10.1002/14651858.CD000543.pub4. PMID: 23076889 Updated. Review.

5

[Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].

Van Gossum A. Van Gossum A. Acta Gastroenterol Belg. 1992 Sep-Dec;55(5-6):462-71. Acta Gastroenterol Belg. 1992. PMID: 1363167 Review. French.

6

Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis.

Feagan BG, Macdonald JK. Feagan BG, et al. Cochrane Database Syst Rev. 2012 Oct 17;10:CD000544. doi: 10.1002/14651858.CD000544.pub3. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 May 09;(5):CD000544. doi: 10.1002/14651858.CD000544.pub4. PMID: 23076890 Updated. Review.

7

Newer pharmacologic agents for the therapy of inflammatory bowel disease.

Ruderman WB. Ruderman WB. Med Clin North Am. 1990 Jan;74(1):133-53. doi: 10.1016/s0025-7125(16)30591-0. Med Clin North Am. 1990. PMID: 2404172 Review.

8

The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.

Bonapace CR, Mays DA. Bonapace CR, et al. Ann Pharmacother. 1997 Jul-Aug;31(7-8):907-13. doi: 10.1177/106002809703100719. Ann Pharmacother. 1997. PMID: 9220055 Review.

9

Oral budesonide for induction of remission in ulcerative colitis.

Sherlock ME, MacDonald JK, Griffiths AM, Steinhart AH, Seow CH. Sherlock ME, et al. Cochrane Database Syst Rev. 2015 Oct 26;2015(10):CD007698. doi: 10.1002/14651858.CD007698.pub3. Cochrane Database Syst Rev. 2015. PMID: 26497719 Free PMC article. Review.

10

The metabolism of mesalamine and its possible use in colonic diverticulitis as an anti-inflammatory agent.

Cohen HD, Das KM. Cohen HD, et al. J Clin Gastroenterol. 2006 Aug;40 Suppl 3:S150-4. doi: 10.1097/01.mcg.0000212654.28527.d0. J Clin Gastroenterol. 2006. PMID: 16885699 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Related Articles by Review for PMID: 31869178

49 results

Results by year